Is bilateral intratympanic (through the eardrum) steroid injection a suitable treatment option for a patient with sudden bilateral sensorineural hearing loss?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 19, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Bilateral Intratympanic Steroid Injection for Bilateral Sudden Sensorineural Hearing Loss

Yes, bilateral intratympanic steroid injections can be administered for bilateral sudden sensorineural hearing loss, particularly when systemic steroids are contraindicated or as salvage therapy after incomplete recovery with initial treatment. 1

Clinical Approach to Bilateral Cases

Bilateral sudden sensorineural hearing loss should immediately alert you to possible systemic disease and requires urgent workup beyond standard unilateral cases. 2 This presentation is uncommon and demands investigation for autoimmune disorders, syphilis, aortitis syndrome, or other systemic etiologies before attributing it to idiopathic causes. 3

First-Line Treatment Strategy

For bilateral sudden sensorineural hearing loss, the treatment approach depends on whether systemic steroids can be safely administered:

If systemic steroids are NOT contraindicated:

  • Initiate oral prednisone 1 mg/kg/day (maximum 60 mg/day) as a single daily dose for 7-14 days, followed by taper 4, 1
  • This remains the standard first-line therapy even for bilateral cases 1
  • Treatment must begin immediately, ideally within 14 days of symptom onset, though benefit has been reported up to 6 weeks 4, 1

If systemic steroids ARE contraindicated:

  • Offer bilateral intratympanic steroid therapy as initial treatment 1
  • Contraindications include insulin-dependent or poorly controlled diabetes, labile hypertension, glaucoma, active tuberculosis, peptic ulcer disease, or prior psychiatric reactions to corticosteroids 1

Bilateral Intratympanic Steroid Protocol

Dosing and Technique

  • Use dexamethasone 24 mg/mL (compounded) or 10 mg/mL (stock), or methylprednisolone 40 mg/mL or 30 mg/mL 4, 1
  • Inject 0.4-0.8 mL into each middle ear space via anterosuperior myringotomy after topical anesthetic 4, 1
  • Patient maintains head in otologic position (affected ear up) for 15-30 minutes per side 1
  • Administer up to 4 injections per ear over a 2-week period 1

Important Technical Considerations

  • Perform audiogram before each subsequent injection to monitor response 4
  • Consider inserting pressure-equalizing tubes if planning multiple injections, though this increases risk of tympanic membrane perforation 4
  • When treating both ears, you can perform injections bilaterally in the same session or stagger them based on patient tolerance 4

Salvage Therapy for Incomplete Recovery

If hearing recovery is incomplete at 2-6 weeks after initial systemic steroid treatment, offer bilateral intratympanic steroid therapy as salvage treatment. 1, 5 The typical salvage protocol involves 4-6 injections of dexamethasone per ear over 2 weeks. 5

Combined intratympanic and systemic steroid therapy has demonstrated superior outcomes compared to systemic steroids alone in poor-prognosis cases, with 75% showing significant improvement versus 41.4% with systemic therapy alone. 6

Critical Monitoring Requirements

Audiometric Assessment

  • Baseline audiometry within 14 days of symptom onset to confirm diagnosis 1
  • Mid-treatment audiograms between intratympanic injections can guide early termination if hearing resolves 1
  • Post-treatment audiogram at completion of treatment course 1
  • Repeat audiometry at 6 months post-treatment regardless of perceived recovery 1

Systemic Disease Workup

Given the bilateral presentation, obtain:

  • MRI of brain and internal auditory canals to rule out vestibular schwannoma or retrocochlear pathology 5, 2
  • Immunologic testing including immune complex levels, particularly in patients over 30 years of age 3
  • Syphilis serology 3
  • Consider evaluation for autoimmune disorders, vasculitis, or other systemic conditions 3, 2

Common Pitfalls to Avoid

Do not assume bilateral treatment is unsafe or impractical - while bilateral sudden sensorineural hearing loss is rare, bilateral intratympanic injections can be safely performed and are explicitly supported by guidelines when systemic steroids are contraindicated. 1

Do not delay audiologic rehabilitation planning - even before knowing the final hearing outcome, counsel patients about hearing aids, cochlear implantation for severe to profound bilateral loss, and other rehabilitation options. 1, 5 Delay leads to auditory deprivation and poorer outcomes. 5

Do not skip the systemic disease workup - bilateral presentation mandates investigation beyond idiopathic causes, as autoimmune and other systemic etiologies may require different long-term management. 3, 2

Do not underdose steroids - whether using oral or intratympanic routes, ensure adequate steroid concentration and duration. 4 A common error is using methylprednisolone dose packs that provide only 105 mg prednisone equivalent over 6 days versus the recommended 540 mg over 14 days. 4

Prognosis and Shared Decision-Making

The evidence supporting corticosteroid therapy remains somewhat equivocal, and potential adverse effects exist, making shared decision-making essential. 4, 1 Patients should understand that one-third to two-thirds may experience spontaneous recovery within the first 2 weeks, and that treatment aims to maximize recovery potential during this critical window. 4, 1

For bilateral cases resulting in severe to profound hearing loss despite treatment, cochlear implantation can successfully restore hearing. 7

References

Guideline

Initial Treatment for Sudden Sensorineural Hearing Loss

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Management of sudden sensorineural hearing loss.

Current opinion in otolaryngology & head and neck surgery, 2016

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Sudden Sensorineural Hearing Loss After Delayed Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Metachronous Sudden Sensorineural Hearing Loss: Patient Characteristics and Treatment Outcomes.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.